Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
Neurourol Urodyn ; 37(4): 1349-1355, 2018 04.
Article in English | MEDLINE | ID: mdl-29130569

ABSTRACT

AIMS: To evaluate the outcomes and complications at long-term follow-up after a Remeex re-adjustable sling for recurrent stress urinary incontinence (rSUI) and intrinsic sphincteric deficiency (ISD) in women. METHODS: Two hundred thirty women with SUI were evaluated after undergoing a re-adjustable sling operation. Twenty-five patients were lost to follow-up, 205 were classified by Q-tip, urodynamic, and clinical criteria into ISD (109) and rSUI (96). Outcome measures included number of pads, 1 h pad-test, urodynamics and subjective satisfaction index with the procedure. RESULTS: After a mean follow-up of 89 months (26-159), 165 patients were cured of SUI (71.7% in the intention to treat analysis (itt), 80.5% in per protocol analysis (pp)). Forty patients remained incontinent (17.4% in itt, 19.5 in pp). Thirty-one patients (15.1%) had detrusor overactivity (DH) incontinence, 21 (10.2%) with de-novo DH and 10 with previous urodynamic mixed incontinence. Eighty-eight patients required re-adjustment of the sling during the follow-up. The tension was increased in 82 cases due to recurrence of SUI and reduced in six due to outlet obstruction. The overall complications rate was 28.8%, (3.4% clavien III). CONCLUSIONS: The Remeex re-adjustable sling provides a good cure rate for rSUI and ISD at long-term follow-up. The complications rate is acceptable since most complications are clavien II. The ability to re-adjust the sling tension during the follow-up allowed us to achieve cure for recurrence after the initial procedure, and to relieve obstruction in every case attempted.


Subject(s)
Suburethral Slings , Urethra/physiopathology , Urinary Incontinence, Stress/surgery , Urodynamics/physiology , Urologic Surgical Procedures/methods , Aged , Female , Humans , Middle Aged , Recurrence , Reoperation , Treatment Outcome , Urethra/surgery , Urinary Incontinence, Stress/physiopathology
2.
Arch Esp Urol ; 64(7): 597-604, 2011 Sep.
Article in English, Spanish | MEDLINE | ID: mdl-21965257

ABSTRACT

OBJECTIVES: Sickle cell disease is one of the most common hereditary diseases, and migration trends and cross breeding have increased its incidence in Europe. While much has been published about the disease, there are few reviews in the literature dealing with its manifestations in the genitourinary system. METHODS: We conducted a comprehensive review, using as our main instrument the PubMed online database, on recent advances in knowledge of the pathophysiology and urological, nephrological, and andrological manifestations of the disease. RESULTS: Manifestations include sickle cell nephropathy, enuresis, nocturia, hematuria, priapism, renal medullary carcinoma, and infarctions and necrosis in various organs of the genitourinary system. CONCLUSIONS: The characteristics of this important disease and the multisystemic spectrum it covers make knowledge of its genitourinary manifestations necessary.


Subject(s)
Anemia, Sickle Cell/complications , Genital Diseases, Female/etiology , Genital Diseases, Male/etiology , Urologic Diseases/etiology , Anemia, Sickle Cell/physiopathology , Female , Genital Diseases, Female/physiopathology , Genital Diseases, Male/physiopathology , Humans , Male , Urologic Diseases/physiopathology
3.
Actas Urol Esp ; 33(6): 712-6, 2009 Jun.
Article in Spanish | MEDLINE | ID: mdl-19711759

ABSTRACT

Urethral cancer is an infrequent pathology, less than 1% of the genitourinary tumors. It is more frequent in women (4:1), in the sixth or seventh decade of life. The most frequent histology being squamous cell carcinoma. First signs and symptoms usually are more attributable to benign stricture disease, rather than malignicy. The interval between the onset of symptoms and diagnosis may be as long as three years. Therefore most of these tumors are locally advanced at the time of diagnosis with generally poor prognosis despite aggressive treatment. Therapeutic management varies with the stage and location of the lesion. Because of the rarity of this pathology, no consensus has been reached on treatment modalities, but seems to be that must be a multimodal one, including surgery, radiotherapy and chemotherapy. We present the case of an 80 year-old male, with a diagnosis of urethral squamous-cell cancer, locally advanced at the time of diagnosis. Surgery was not feasible. The patient underwent chemotherapy and radiotherapy with evidence of quick progression thereafter.


Subject(s)
Carcinoma, Squamous Cell/secondary , Urethral Neoplasms/secondary , Aged, 80 and over , Carcinoma, Squamous Cell/diagnosis , Humans , Male , Urethral Neoplasms/diagnosis
SELECTION OF CITATIONS
SEARCH DETAIL
...